The Curbsiders Internal Medicine Podcast#528 Hospital Addiction Medicine 3.0 with Dr. Maggie Lowenstein

Hidden Adulterant Metametamine

38:47–39:46 · 59s

Dr. Lowenstein reveals a new alpha-2 agonist, metametamine, now pervasive in Philadelphia’s fentanyl supply and causing a distinct withdrawal syndrome unresponsive to usual opioid treatments.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.